Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco pioneer DTC online eyewear at $6.95+ complete glasses with 50M+ pairs sold; privately-held disrupting traditional optical retail competing with Warby Parker and EyeBuyDirect for affordable prescription glasses online.
Zenni Optical is a San Francisco-based direct-to-consumer online eyewear retailer — privately held, founded in 2003 by Jing Wang and Julia Zhen — pioneering the online prescription glasses market by offering hundreds of frame styles with prescription lens fulfillment starting from as low as $6.95, making vision correction accessible at a fraction of the $200-800+ price of traditional optical retail. Estimated at $400+ million in annual revenue with 50+ million pairs of glasses sold to 50+ million customers in over 50 countries, Zenni's low-cost manufacturing (frames produced at owned factories in China) and direct-to-consumer model (no distributor or retailer markup layers) enable the dramatic price advantage over LensCrafters, Sunglass Hut, and independent opticians that made Zenni one of the first successful DTC disruptors.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.